Nerve zap could ease chronic headache from painkiller overuse
NCT ID NCT07360782
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a procedure called occipital nerve pulsed radiofrequency for people with medication overuse headache. The treatment uses a short electrical pulse on nerves at the back of the head to try to reduce headache days. 90 adults will be randomly assigned to get the procedure plus standard care, or standard care alone, and tracked for 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- greater occipital nerve pulsed radiofrequency (GONPRF) procedure
- What this could lead to
- If it works, this could offer a new way to reduce headache days for people with medication overuse headache, possibly helping them rely less on painkillers.
- What could go wrong
- This is a small, early-stage trial with only 90 people. The procedure may not work better than standard care, and there are risks like pain or nerve damage from the injection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDICATION OVERUSE HEADACHE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital
RECRUITINGAnkara, 06800, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Thousands to test new migraine meds in largest Real-Life study
- Nerve block injection may ease migraine drug withdrawal
- Can a nerve block cure your headache? new study investigates
- Zapping away migraines: brain stimulation shows promise for chronic sufferers
- 10,000 headache patients join landmark registry study
- New migraine drug shows promise for those caught in a Headache-Medication cycle